Cancer statistics in China, 2015

Ca-A Cancer Journal for Clinicians - Tập 66 Số 2 - Trang 115-132 - 2016
Wanqing Chen1, Rongshou Zheng2, Peter D. Baade3, Siwei Zhang4, Hongmei Zeng4, Freddie Bray5, Ahmedin Jemal6, Xue Qin Yu7,8, Jie He9
1Deputy Director, National Office for Cancer Prevention and Control National Cancer Center Beijing China
2Associate Researcher, National Office for Cancer Prevention and Control National Cancer Center Beijing China
3Senior Research Fellow Cancer Council Queensland Brisbane Queensland Australia
4Associate Professor, National Office for Cancer Prevention and Control National Cancer Center Beijing China
5Head, Section of Cancer Surveillance International Agency for Research on Cancer Lyon France
6Vice President, Surveillance and Health Services Research Program American Cancer Society Atlanta GA
7Adjunct Lecturer, Sydney School of Public Health University of Sydney Sydney New South Wales Australia
8Research Fellow Cancer Council New South Wales Sydney New South Wales Australia
9Director National Cancer Center Beijing China.

Tóm tắt

With increasing incidence and mortality, cancer is the leading cause of death in China and is a major public health problem. Because of China's massive population (1.37 billion), previous national incidence and mortality estimates have been limited to small samples of the population using data from the 1990s or based on a specific year. With high‐quality data from an additional number of population‐based registries now available through the National Central Cancer Registry of China, the authors analyzed data from 72 local, population‐based cancer registries (2009‐2011), representing 6.5% of the population, to estimate the number of new cases and cancer deaths for 2015. Data from 22 registries were used for trend analyses (2000‐2011). The results indicated that an estimated 4292,000 new cancer cases and 2814,000 cancer deaths would occur in China in 2015, with lung cancer being the most common incident cancer and the leading cause of cancer death. Stomach, esophageal, and liver cancers were also commonly diagnosed and were identified as leading causes of cancer death. Residents of rural areas had significantly higher age‐standardized (Segi population) incidence and mortality rates for all cancers combined than urban residents (213.6 per 100,000 vs 191.5 per 100,000 for incidence; 149.0 per 100,000 vs 109.5 per 100,000 for mortality, respectively). For all cancers combined, the incidence rates were stable during 2000 through 2011 for males (+0.2% per year; P = .1), whereas they increased significantly (+2.2% per year; P < .05) among females. In contrast, the mortality rates since 2006 have decreased significantly for both males (−1.4% per year; P < .05) and females (−1.1% per year; P < .05). Many of the estimated cancer cases and deaths can be prevented through reducing the prevalence of risk factors, while increasing the effectiveness of clinical care delivery, particularly for those living in rural areas and in disadvantaged populations. CA Cancer J Clin 2016;66:115–132. © 2016 American Cancer Society.

Từ khóa


Tài liệu tham khảo

National Bureau of Statistics of China, 2010, China Statistical Yearbook, 2010

10.1158/1055-9965.EPI-04-0680

10.1186/s40880-015-0001-2

Chen W, 2014, Annual report on status of cancer in China, 2010, Chin J Cancer Res., 26, 48

10.1016/S0140-6736(05)67344-8

National Cancer Center, Disease Prevention and Control Bureau, Ministry of Health, 2012, Chinese Cancer Registry Annual Report 2012

Ferlay J, 2005, Check and Conversion Programs for Cancer Registries (IARC/IACR Tools for Cancer Registries). IARC Technical Report No. 42

Chen W, 2014, Report of cancer incidence and mortality in China, 2010 [serial online], Ann Transl Med., 2, 61

10.5732/cjc.013.10018

International Association of Cancer Registries, 2005, International rules for multiple primary cancers, Asian Pac J Cancer Prev., 6, 104

Li GL, 2009, Representativeness of population‐based cancer registration in China—comparison of urban and rural areas, Asian Pac J Cancer Prev., 10, 559

10.1186/1471-2407-13-458

10.1186/1478-7954-3-3

10.1093/eurpub/ckq120

10.1016/j.ejca.2008.11.033

National Cancer Institute.Joinpoint Regression Program Version 4.2.0‐April 2015. Bethesda MD: Statistical Methodology and Applications Branch Surveillance Research Program National Cancer Institute;2015.

10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z

10.1002/ijc.2910020310

Chen Z, 2008, National Death Survey Report 2004–2005

10.7314/APJCP.2014.15.1.191

10.1186/s12939-015-0211-x

10.1111/1759-7714.12169

FerlayJ SoerjomataramI ErvikM et al.GLOBOCAN 2012 v1.0 Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon France: International Agency for Research on Cancer;2013.globocan.iarc.fr. Accessed June 19 2015.

Howlader N, 2015, SEER Cancer Statistics Review, 1975–2012

10.3322/caac.21262

10.3322/caac.21254

10.1002/ijc.29227

10.1038/sj.bjc.6601813

Forman D, 2014, Cancer Incidence in Five Continents

10.1016/j.ejca.2008.11.032

10.1056/NEJMc1102459

10.1016/j.puhe.2009.09.021

US Department of Health and Human Services.The Health Consequences of Smoking—50 Years of Progress. A Report of the Surgeon General. Atlanta GA: US Department of Health and Human Services Centers for Disease Control and Prevention National Center for Chronic Disease Prevention and Health Promotion Office on Smoking and Health;2014.

10.1016/j.puhe.2006.07.023

10.1016/S0140-6736(14)62038-9

10.1038/nrurol.2014.42

10.12954/PI.12014

10.1002/mnfr.200700511

10.1016/S1470-2045(14)70029-4

10.1016/S1470-2045(14)70056-7

10.1007/s11670-012-0009-y

10.1634/theoncologist.2014-0303

10.1002/ijc.27571

10.1016/j.vaccine.2012.07.055

10.1634/theoncologist.2013-0123

10.1007/s10552-011-9852-2

10.1007/s10552-008-9260-4

10.1089/thy.2013.0045

10.1111/cen.12724

10.1136/bmj.f4706

10.1186/1471-2407-14-975

10.1007/s10552-011-9791-y

Li RC, 2004, Efficacy of hepatitis B vaccination on hepatitis B prevention and on hepatocellular carcinoma [article in Chinese], Zhonghua Liu Xing Bing Xue Za Zhi., 25, 385

10.1056/NEJM199706263362602

10.2131/jts.23.SupplementII_143

10.1016/j.vaccine.2009.08.048

10.1093/annonc/mds139

10.1002/cncr.29560

10.1111/j.1440-1843.2011.02062.x

10.1016/S0140-6736(15)00340-2

10.1097/JTO.0b013e31818020eb

10.1002/cncr.29603

10.1016/S0140-6736(15)60174-X

10.1002/cncr.29600

10.1016/S0140-6736(15)61409-X

2015, Will China make the great leap in tobacco control in 2015 [editorial]?, Lancet., 385, 2122

10.1016/S0140-6736(10)60062-1

10.1016/S1470-2045(13)70065-2

Ministry of Environmental Protection.China to spend trillions on pollution battle.english.mep.gov.cn/News_service/media_news/201307/t20130729_256489.htm#. Accessed October 13 2015.

Kang LN, 2014, Cancer screening and prevention in China [serial online], Cancer Control 2014., 131

10.1016/S1470-2045(10)70273-4

10.1200/JCO.2014.58.0423

10.1002/ijc.29877

10.1002/cncr.29584

10.1056/NEJMoa1102873

10.1016/S1470-2045(15)00223-5

10.1371/journal.pmed.1001694

10.1016/S0140-6736(11)61880-1

10.1016/S1470-2045(12)70403-5

10.1038/bjc.2013.6

10.1038/sj.bjc.6602154

Ferlay J, 2010, Cancer Incidence in Five Continents, Volumes I to IX: IARC CancerBase No. 9 [Internet]

10.1002/ijc.28990